Is subretinal surgery feasible for a non-responsive juxtafoveal type 2 choroidal neovascular membrane?

Purpose: To describe the long-term outcome of a patient with multifocal choroiditis, who underwent surgical removal of a type 2 choroidal neovascular membrane employing 23 G pars plana vitrectomy. Observations: A 50-year-old man was treated with 3 monthly intravitreal bevacizumab injections, but des...

Full description

Bibliographic Details
Main Authors: Hugo Quiroz-Mercado, Andrés Lisker-Cervantes, Luis Arroyo, Naresh Mandava, Frank S. Siringo, Miguel Paciuc-Beja, Roberto Gonzalez-Salinas
Format: Article
Language:English
Published: Elsevier 2019-09-01
Series:American Journal of Ophthalmology Case Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2451993618301476
Description
Summary:Purpose: To describe the long-term outcome of a patient with multifocal choroiditis, who underwent surgical removal of a type 2 choroidal neovascular membrane employing 23 G pars plana vitrectomy. Observations: A 50-year-old man was treated with 3 monthly intravitreal bevacizumab injections, but despite treatment, visual acuity continued to worsen from 20/40 to 20/100, and bleeding was not receding. A minimal invasive pars plana vitrectomy was performed for surgical removal of the neovascular complex without any complicating incident. Subsequent visual acuity was 20/25 for more than eleven years. Conclusions and Importance: Surgical removal of choroidal neovascular membranes employing minimal invasive surgery in addition to anti-VEGF therapy, and OCT evaluation can be a viable approach for selected cases of juxtafoveal type 2 CNV. Keywords: Choroidal neovascular membrane, Spectral-domain optical coherence tomography, Pars plana vitrectomy, Anti-VEGF therapy
ISSN:2451-9936